DE60134469D1 - Humane epitheliale zellen von müllerian ductus-abstammende, verfahren zur ihrer isolierung und verwendungen davon - Google Patents

Humane epitheliale zellen von müllerian ductus-abstammende, verfahren zur ihrer isolierung und verwendungen davon

Info

Publication number
DE60134469D1
DE60134469D1 DE60134469T DE60134469T DE60134469D1 DE 60134469 D1 DE60134469 D1 DE 60134469D1 DE 60134469 T DE60134469 T DE 60134469T DE 60134469 T DE60134469 T DE 60134469T DE 60134469 D1 DE60134469 D1 DE 60134469D1
Authority
DE
Germany
Prior art keywords
epithelial cells
müllerian
derived epithelial
abstammende
ductus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60134469T
Other languages
German (de)
English (en)
Inventor
Ronghao Li
Jennie Powell Mather
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Raven Biotechnologies Inc
Original Assignee
Raven Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raven Biotechnologies Inc filed Critical Raven Biotechnologies Inc
Application granted granted Critical
Publication of DE60134469D1 publication Critical patent/DE60134469D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60134469T 2000-04-07 2001-04-04 Humane epitheliale zellen von müllerian ductus-abstammende, verfahren zur ihrer isolierung und verwendungen davon Expired - Lifetime DE60134469D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/545,435 US6416999B1 (en) 2000-04-07 2000-04-07 Human Müllerian duct-derived epithelial cells and methods of isolation and uses thereof
PCT/US2001/010998 WO2001077298A2 (en) 2000-04-07 2001-04-04 Human müllerian duct-derived epithelial cells and methods of isolation and uses thereof

Publications (1)

Publication Number Publication Date
DE60134469D1 true DE60134469D1 (de) 2008-07-31

Family

ID=24176236

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60134469T Expired - Lifetime DE60134469D1 (de) 2000-04-07 2001-04-04 Humane epitheliale zellen von müllerian ductus-abstammende, verfahren zur ihrer isolierung und verwendungen davon

Country Status (11)

Country Link
US (2) US6416999B1 (enExample)
EP (1) EP1276850B1 (enExample)
JP (1) JP4748700B2 (enExample)
KR (1) KR100748039B1 (enExample)
CN (1) CN1423692A (enExample)
AT (1) ATE398671T1 (enExample)
AU (2) AU2001251311B2 (enExample)
CA (1) CA2404634A1 (enExample)
DE (1) DE60134469D1 (enExample)
DK (1) DK1276850T3 (enExample)
WO (1) WO2001077298A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416999B1 (en) * 2000-04-07 2002-07-09 Raven Biotechnologies, Inc. Human Müllerian duct-derived epithelial cells and methods of isolation and uses thereof
WO2003068938A2 (en) * 2002-02-12 2003-08-21 Raven Biotechnologies, Inc Human fetal bladder-derived epithelial cells
CA2486548A1 (en) * 2002-05-30 2003-12-11 Raven Biotechnologies, Inc. Animal model for toxicology and dose prediction
EP1565489B1 (en) 2002-06-19 2010-11-17 Raven Biotechnologies, Inc. Internalizing antibodies specific for the RAAG10 cell surface target
EP1581096A4 (en) * 2002-11-13 2006-06-21 Raven Biotechnologies Inc ANTIGEN PIPA AND BINDING ANTIBODIES THEREOF
AP2949A (en) 2006-03-07 2014-07-31 Shroff Geeta Compositions comprising human embryonic stem cellsand their derivatives, methods of use, and method s of preparation
CN101855339A (zh) * 2007-01-22 2010-10-06 雷文生物技术公司 人类癌症干细胞
JP5883384B2 (ja) 2009-08-13 2016-03-15 ザ ジョンズ ホプキンス ユニバーシティー 免疫機能を調節する方法
CN102732479B (zh) * 2011-03-31 2014-08-27 北京大学 胸腺上皮前体细胞的制备方法及其专用培养基
AU2013248265B2 (en) * 2012-11-08 2018-11-01 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
CN108061804B (zh) * 2016-11-09 2020-05-12 北京大学人民医院 用于诊断子宫内膜异位症的生物标志物
CN107475369B (zh) * 2017-07-07 2021-05-04 南方医科大学 Hoxa9基因在制备治疗皮肤鳞状细胞癌药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69623109T2 (de) * 1996-04-19 2002-12-12 Societe Des Produits Nestle S.A., Vevey Menschliche immortalisierte Colon-Epithelialzellen
US6004528A (en) 1997-09-18 1999-12-21 Bergstein; Ivan Methods of cancer diagnosis and therapy targeted against the cancer stemline
US6416999B1 (en) * 2000-04-07 2002-07-09 Raven Biotechnologies, Inc. Human Müllerian duct-derived epithelial cells and methods of isolation and uses thereof

Also Published As

Publication number Publication date
EP1276850A2 (en) 2003-01-22
EP1276850B1 (en) 2008-06-18
CN1423692A (zh) 2003-06-11
WO2001077298A2 (en) 2001-10-18
CA2404634A1 (en) 2001-10-18
WO2001077298A3 (en) 2002-07-04
DK1276850T3 (da) 2008-10-13
KR100748039B1 (ko) 2007-08-09
KR20030032933A (ko) 2003-04-26
JP4748700B2 (ja) 2011-08-17
US20030040110A1 (en) 2003-02-27
US7125713B2 (en) 2006-10-24
AU5131101A (en) 2001-10-23
ATE398671T1 (de) 2008-07-15
US6416999B1 (en) 2002-07-09
JP2003530100A (ja) 2003-10-14
AU2001251311B2 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
DE60125342D1 (de) Humane pankreatische epitheliale stammzellen, verfahren zur ihrer isolierung und verwendungen davon
DE60134469D1 (de) Humane epitheliale zellen von müllerian ductus-abstammende, verfahren zur ihrer isolierung und verwendungen davon
ATE407138T1 (de) Verfahren zur herstellung interferierender rna- moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
WO2002083864A3 (en) Methods and reagents for cell transplantation
DE60233248D1 (de) Verfahren zur isolierung, expansion und differenzierung fötaler stammzellen aus chorionzotte, fruchtwasser und plazenta und therapeutische verwendungen davon
EP2722387A3 (en) Definitive endoderm
ATE489119T1 (de) Plasmaprotein-matritzes und verfahren zu ihrer herstellung
DE50114426D1 (de) Verfahren zur herstellung gebrauchsfertiger, antigenbeladener oder -unbeladener, kryokonservierter, reifer dendritischer zellen
ATE505533T1 (de) Antigenpräsentierende zellen, verfahren zu ihrer herstellung sowie ihre verwendung für krebsimpfstoffe
EP2471903A3 (en) Placental stem cell populations
CN106676075B (zh) 一种孤雌单倍体胚胎干细胞及其制备与应用
AU2002359522A1 (en) Compositions and methods of selective nucleic acid isolation
ATE493492T1 (de) Verfahren und system zur herstellung von stammzellen aus fettgewebe
EP2213741A3 (en) Compositions and methods of using a synthetic DNAse I
IL178305A0 (en) Microelectromechanical devices useful for manipulating cells or embryos, kits thereof, methods of making same, and methods of use thereof
WO2005113747A3 (de) Multizelluläre gewebe- und organkultursysteme
DE60221224D1 (de) Verfahren und vektoren für die plastiden-transformation von höheren pflanzen
IL161873A0 (en) Production of cell suspensions
DE60231020D1 (de) Membran zur Gastrennung und Verfahren zu ihrer Herstellung
WO2003068938A3 (en) Human fetal bladder-derived epithelial cells
WO2003010292A3 (en) Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors
ATE521697T1 (de) Verfahren zum wachstum von menschlichen bindehautgewebeäquivalenten für die forschung, die klinische augenoberflächentransplantation und die geweberekonstruktion
WO2004078944A3 (en) Thrombin, soluble jaggedi, and trap and growth of stem cells
WO2002034887A3 (en) Maturation of dendritic cells
ATE520770T1 (de) Humane eierstockmesothelialzellen und verfahren zu deren isolierung und verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1276850

Country of ref document: EP

Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN, DE